objeCtives: Identify the principal challenges faced during migration from paper to electronic platform when placeholders are used within translated content, as eCOA questionnaires will often use placeholders which are replaced by other words/numbers when the software is running (string concatenation) Methods: 110 reviews across 22 languages were collated; languages facing issues with placeholders were identified; problems and resolutions were compared and results were reviewed in order to identify patterns. Results: Just over 40% of languages had issues with the population of software placeholders. Two main problems were found: (1) Issues involving articles and pronouns (including use of multiple articles/neutral pronouns/other gender agreements) -For example, Italian uses articles (al/alla) before a noun, so when a noun of either gender is electronically inserted into a sentence, the simplest resolution was to include all variations of the article before every placeholder. However in French where 3 kinds of article were required the result was too long, and a gender-neutral pronoun was used.
(2) Some languages use two or more noun cases which raised issues. For example, Czech nouns change form depending on how they're used in sentences but the running software inserted the same form of the noun everywhere. It was decided that the auto-populated text would be altered to fit the majority of cases, and instances which were an exception would be replaced with static text to ensure they appeared correctly. ConClusions: There are frequently issues with string concatenation that require in-depth discussion, as very few languages function in the same way as English. However, the issues that arose here could be resolved with careful consideration between the lead linguist and the project manager. All challenges were dealt with on an individual basis to attain a translation that reflects the source in the most natural way possible whilst still remaining true to the source.
PRM187 PAtient RePoRteD outCoMes in the DeveloPMent oF new MeDiCAtions FoR tyPe 2 DiAbetes: A Review oF ReCently APPRoveD PRoDuCts
Reaney M 1 , Celeste Elash CA 2 1 ERT, Peterborough, UK, 2 ERT, Pittsburgh, PA, USA objeCtives: Patient-Reported Outcome (PRO) instruments are increasingly being utilized in drug development to provide a holistic understanding of the drugs impact. Such data can be beneficial in clinical decision making. This review sought to identify and discuss the PRO instruments used in Phase 3 trials of the newer classes of drugs for the treatment of Type 2 diabetes (T2DM). Methods: A search was conducted in medline, psychinfo, cinahl, and clinicaltrials.gov using 17 drug names contained within the following classes: GLP-1 receptor agonists, novel insulins, SGLT-2 inhibitors, and DPP-4 inhibitors. This search was supplemented with EASD and ADA abstract database searches from 2012-2014. PRO instruments used in Phase 3 trials were identified and categorized by measurement concept(s). The items and domains contained within the PRO instruments were further explored and summarized. Results: Twenty PRO instruments have been used, although none in DPP-4 inhibitor trials. PRO instruments were used to measure six separate concepts: treatment satisfaction (10/17 drugs), healthrelated quality of life (HRQoL) (8/17), impact of weight/eating-related outcomes (6/17), symptoms of diabetes (3/17), psychological well-being (3/17), and cognitive functioning (1/17). Although several PRO instruments were used to measure the same concept, the items and domains that comprised that concept differed across instruments. For example, only two of the seven treatment satisfaction questionnaires contain items pertaining to the injectable therapy device. In addition, some PRO instruments did not comprehensively evaluate the concept that they claimed. For example, an item-level analysis of the EQ-5D, identified as a measurement of HRQoL, suggests that it more accurately measures functional health status, thereby representing only one dimension of HRQoL. ConClusions: PRO data are available for many recently approved drugs in T2DM. More work is needed to highlight the relevance and importance of PRO data from pivotal trials as an important consideration for physicians when making treatment decisions. objeCtives: To develop a checklist of essential items, which authors should consider when reporting studies of mapping to preference-based measures from other outcome measures. The aim of the checklist (the MApping onto Preference-based measures reporting Standards (MAPS) statement) is to promote complete and transparent reporting by researchers. Methods: A working group of health economists and a Delphi methodologist was convened. Candidate items for the checklist were identified through a structured review of the literature and reviewed by the working group. A modified Delphi survey, with representatives from academia, consultancy, health technology assessment agencies and the biomedical journal editorial community, was used to identify a list of essential reporting items from the set of canwith MTX alone or in combination, to explore their experience. Qualitative analysis was performed to develop a conceptual model of the factors influencing adherence to MTX. Based on this model, items were generated using patients' verbatim, and comprehension tested with 18 RA patients. Acceptability and applicability of the resulting pilot version were then assessed in clinical practice during consultation, with 10 rheumatologists, using the PRAgmatic Content and face validity Test. Results: Several factors associated with poor adherence to MTX were elicited from the analysis of the exploratory interviews: barriers (practical, physical, emotional, cognitive, financial), side effects, treatment perceived efficacy; doctor-related factors, patients' beliefs, expectations and behaviors towards treatment, and external sources. The resulting MTX Adherence Questionnaire included 29 questions, plus three about MTX administration mode and dose, divided into 5 sections: "Practical aspects of MTX"; "Me and MTX"; "Efficacy of MTX"; "My feelings about MTX"; "My opinion regarding my care"; "MTX treatment in general". Rheumatologists accepted very well the questionnaire and found it useful to enhance communication with their patients (n= 8/10). ConClusions: The MTX Adherence Questionnaire is a patient self-administered tool that identifies patients facing adherence issues with MTX, and thereby helps clinicians make better-informed treatment decisions. It is suitable for use in clinical practice. A validation study to assess its robustness in research and clinical practice is being set up. objeCtives: Patients with chronic inflammatory disorders, such as rheumatoid arthritis (RA) or spondyloarthritis (SpA), have personal sets of fears and beliefs related to their disease that may influence the patient-physician relationship and treatment adherence. The objective was to describe the most frequent fears and beliefs in RA and SpA patients. Methods: Cross-sectional assessment of unselected patients with a diagnosis of RA (ACR/EULAR criteria) or axial SpA (axSpA) (ASAS criteria) in France in 2014. The study was proposed to all rheumatologists in France. A self-reported 44-item questionnaire (25 items on fears, 19 on beliefs) was built and preliminarily validated for this study. Each item was scored 0-10 (10 indicating higher fears/stronger beliefs). The analysis was descriptive for the 5 fears and 5 beliefs most frequently scored as ≥ 7/10, in both axSpA and RA patients. Results: Overall, 226 patients (161 RA, 65 axSpA; 64.4% female) were analyzed: mean disease duration 11.9 vs 13.8 years and mean patient's global assessment 31/100 vs 41/100 for RA vs axSpA patients, respectively. Of the 25 listed fears, the 6 most frequently reported were: "afraid of suffering again" (66.7% scored this as ≥ 7/10), "afraid of losing control and autonomy" (61.4%), "afraid of being a burden for relatives" (59.6%), "afraid of losing all joint mobility" (58.9%), "afraid of the spread of the disease to other joints" (58.6%) and "afraid of the consequences of my disease on my professional activity" (58.6%). Of the 19 listed beliefs, the 5 most frequently reported were: "flares are triggered by fatigue" (41.7%), "physical activity reduces flares" (38.7%), "flares are triggered by changes in the weather" (37.3%), "flares are triggered by physical effort" (37.1%) and "the disease is linked to a genetic cause" (36.9%). ConClusions: This study highlights the main fears and beliefs from a patient perspective using a novel questionnaire specific to chronic inflammatory arthritis. objeCtives: Currently there is no standardized tool or questionnaire to measure workability and related concepts. Instead, there are various different instruments researchers and practitioners can choose between. However, a comprehensive review is still lacking and there is no evidence which instruments are used in practice. The objective of this paper is to identify, describe and evaluate the existing instruments for measuring workability, presenteeism, productivity and related concepts and to assess the status quo regarding the use and awareness of the instruments in Germany. Methods: We adopted a 2-step-approach: (1) PubMed, the Cochrane Library and ScienceDirect were searched for relevant articles published before August 2014. Internet search and scanning reference lists complemented our search. Two authors independently reviewed titles, assessed articles' eligibility and extracted relevant data. Instruments identified in literature were briefly described and evaluated. (2) Experts from rehabilitation, health management/economics and representatives of the medical profession were interviewed on their experiences with measuring workability. The survey was based on a semi-standardized, structured guideline and conducted by telephone. Results: (1) Systematic review revealed 4665 articles. Thereof 357 were included in further research. In total, we identified 57 instruments (including different versions of single instruments). Instruments vary significantly regarding content, response format, length, etc. Instruments most often used include WPAI, WLQ, SPS, HPQ, HLQ, WAI and MIDAS. (2) Results of the interviews indicate that the WAI and WPAI are the instruments most common and also most often used in Germany. Both tools are considered appropriate for measuring workability and experiences are
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